Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC Navitoclax-d8 | 1217620-38-6 | 99.7% | 982.66 | C47H47D8ClF3N5O6S3 | 1 MG
SDP

Catalog No. 5000211788
Encompass_Preferred

Navitoclax-d8 is the deuterium-labeled analog of navitoclax (ABT-263), a potent inhibitor of anti-apoptotic Bcl-2 family proteins. Supplied as a 1 mg stable-isotope reference, it is intended for use in mass spectrometry, pharmacokinetic, and mechanistic research where isotopic tracing or internal standards are required.

  • Deuterium-labeled (d8) analog for clear mass shift in MS analyses.
  • High purity offering reliable analytical performance.
  • Suitable as an internal standard for pharmacokinetic studies.
  • Supplied in a low-mass format for specialized research applications.
  • Stable under recommended storage for long-term use.

Catalog No. 50-002-11788 Supplier Medchemexpress LLC Supplier No. HY10087S1MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Navitoclax-d8 is the deuterium-labeled analog of navitoclax (ABT-263), a potent inhibitor of anti-apoptotic Bcl-2 family proteins. Supplied as a 1 mg stable-isotope reference, it is intended for use in mass spectrometry, pharmacokinetic, and mechanistic research where isotopic tracing or internal standards are required.

  • Deuterium-labeled (d8) analog for clear mass shift in MS analyses.
  • High purity offering reliable analytical performance.
  • Suitable as an internal standard for pharmacokinetic studies.
  • Supplied in a low-mass format for specialized research applications.
  • Stable under recommended storage for long-term use.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.